User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Search results

  1. Congress Report: 17th American Diabetes Association (ADA) meeting

    ... from several studies of diabetes medications including the insulin degludec DEVOTE study, 1 canagliflozin in the CANVAS program, 2 ... the cardiovascular ( CV ) safety of insulins degludec and glargine in patients with type 2 diabetes (T2D) at high risk of cardiovascular ...

  2. Congress report: 72nd American Diabetes Association meeting

    ... Tags Adolescence T2DM in adolescents Insulin use long-term Specialty area(s) Endocrinology and ... cancer or cardiovascular-related deaths from taking insulin glargine as compared to not taking insulin. Not only that, but insulin therapy ...

  3. Highlights from the 18th American Diabetes Association meeting (ADA), Orlando, USA, June 22–27th 2018

    ... in A1C, body weight, fasting glucose, blood pressure and insulin doses, along with improvements in quality of life. But research has ... either 12 months of metformin or 3 months of the insulin glargine followed by 9 months of metformin. After 12 months, medications were ...

  4. EASD Conference 2012: Highlights from the European Society for the Study of Diabetes-EASD 2012

    ... a second or third oral drug or of an injective agent, i.e. insulin or GLP-1 agonists, is appropriate when  a more appropriated metabolic ... cancer. Whether insulin analogues or secretagouges, such as glargine and sulfonylureas, may increase cancers’ incidence is still debated, ...

  5. Scientific Highlights: 2016 Latin American conference on cardiometabolic diseases management: health emergencies in focus

    ... diabetes prevention to be off-label. Metformin improves insulin sensitivity and reduces fasting or postprandial glucose levels; it also ... and detemir (FDA pregnancy category B) Insulin analogues glargine, degludec and glulisine (FDA pregnancy category C) Therapy should ...